138 filings
Page 2 of 7
8-K
4tnabzk3u3gef1i6
2 Aug 23
Allogene Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
4:04pm
8-K
chqsbw y0s6qviso
21 Jun 23
Other Events
4:05pm
8-K
udd0t5 r8t
15 Jun 23
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
13fyn 8jhx
14 Jun 23
Departure of Directors or Certain Officers
8:04am
8-K
4ns70dv
7 Jun 23
Other Events
4:16pm
8-K
8u9gyb
3 May 23
Allogene Therapeutics Reports First Quarter 2023 Financial Results and Business Update
4:05pm
ARS
8uod8dfzmva1w1f3h2b
24 Apr 23
Annual report to shareholders
4:11pm
DEFA14A
edp9sded04t4h
24 Apr 23
Additional proxy soliciting materials
4:09pm
8-K
yzoptjsjfb4c ut
20 Apr 23
Departure of Directors or Certain Officers
4:08pm
8-K
1uidq5x8
10 Mar 23
Regulation FD Disclosure
4:00pm
S-8
k618yi a6d2ic0
28 Feb 23
Registration of securities for employees
4:27pm
8-K
v5h3vk hxi
28 Feb 23
Allogene Therapeutics Reports Fourth Quarter and Full Year 2022
4:07pm
8-K
2rkgcqfcr1ij9sgm 0l
3 Jan 23
Departure of Directors or Certain Officers
8:05am
8-K
r60uh7v u9byt
29 Nov 22
Other Events
3:33pm
S-3ASR
b68gh8678zv r1
2 Nov 22
Automatic shelf registration
4:43pm
8-K
dwwbuypjz0
2 Nov 22
Allogene Therapeutics Reports Third Quarter 2022 Financial Results and Announces Investor R&D Showcase
4:16pm